Filana Therapeutics (FLNA) Accounts Payables (2010 - 2023)
Filana Therapeutics (FLNA) posted quarterly Accounts Payables of $10.3 million for Q2 2023, up 117.28% year-over-year from $4.8 million in Q2 2022, and up 25.43% quarter-over-quarter from $8.2 million in Q1 2023.
Filana Therapeutics (FLNA) Accounts Payables (2010 - 2023) Analysis & Trends
Filana Therapeutics' Accounts Payables history runs 14 years deep, the most recent figure standing at $10.3 million for Q2 2023.
- In Q2 2023, Accounts Payables rose 117.28% year-over-year to $10.3 million; the TTM figure through Jun 2023 stood at $10.3 million (up 117.28% YoY), while the FY2022 annual figure was $4.0 million, down 43.63% from the prior year.
- Accounts Payables for Q2 2023 stood at $10.3 million, up from $8.2 million in the prior quarter.
- The five-year high for Accounts Payables was $10.3 million in Q2 2023, with the low at $340000.0 in Q3 2019.
- The 5-year median for Accounts Payables is $1.4 million (2020), against an average of $2.8 million.
- The sharpest annual moves came in 2021 and 2022: Accounts Payables soared 682.22% in 2021, then plunged 43.63% in 2022.
- Filana Therapeutics' Accounts Payables stood at $453000.0 in 2019, then jumped by 101.1% to $911000.0 in 2020, then jumped by 682.22% to $7.1 million in 2021, then sank by 43.63% to $4.0 million in 2022, then surged by 157.36% to $10.3 million in 2023.
- Business Quant data shows FLNA's Accounts Payables at $10.3 million in Q2 2023, $8.2 million in Q1 2023, and $4.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 35.57 Mn |
| 10 | Filana Therapeutics | 45.79 Mn | 45.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 10.34 Mn |
| Mar 31, 2023 | 8.24 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 3.53 Mn |
| Jun 30, 2022 | 4.76 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 7.13 Mn |
| Sep 30, 2021 | 2.35 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Mar 31, 2021 | 864,000.00 |
| Dec 31, 2020 | 911,000.00 |
| Sep 30, 2020 | 465,000.00 |
| Jun 30, 2020 | 416,000.00 |
| Mar 31, 2020 | 608,000.00 |
| Dec 31, 2019 | 453,000.00 |
| Sep 30, 2019 | 340,000.00 |
| Jun 30, 2019 | 594,000.00 |
| Mar 31, 2019 | 495,000.00 |
| Dec 31, 2018 | 294,000.00 |
| Sep 30, 2018 | 549,000.00 |